View in EDS

Improvements in Workplace and Household Productivity Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in Dmard-Naive Patients with Severe, Active and Progressive Rheumatoid Arthritis: Results from the C-Early Randomized, Double-Blind, Controlled Phase 3 Study.

Saved in:

Bibliographic Details
Title:	Improvements in Workplace and Household Productivity Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in Dmard-Naive Patients with Severe, Active and Progressive Rheumatoid Arthritis: Results from the C-Early Randomized, Double-Blind, Controlled Phase 3 Study.
Authors:	Emery, P¹, Bingham, C², Burmester, GR³, Bykerk, VP⁴, Furst, D⁵, Mariette, X⁶, Purcaru, O⁷, VanLunen, B⁸, Weinblatt, M⁹, Burmester, G R³ (AUTHOR), Bykerk, V P⁴ (AUTHOR)
Source:	Value in Health. Nov2015, Vol. 18 Issue 7, pA710-A710. 1p.
Database:	Academic Search Ultimate

Description
ISSN:	10983015
DOI:	10.1016/j.jval.2015.09.2671